论文信息 - A 40 Month Double-Blind, Randomized, Placebo-Controlled Trial on the Effect of BCc1 Nanomedicine on Survival of Metastatic and Non-Metastatic Gastric Cancer Patients - 字舞流文

A 40 Month Double-Blind, Randomized, Placebo-Controlled Trial on the Effect of BCc1 Nanomedicine on Survival of Metastatic and Non-Metastatic Gastric Cancer Patients

M. Akbari | Vahid Kaveh | M. Hafizi | S. Noorian | M. Khayamzadeh | Saideh Fakharzadeh | S. Kalanaky | M. Nazaran | A. Jenabian | M. M. A. Sereshki | Behrooz Gharib | H. Mirzaee | M. Razavi | Saeid Salimi | Hossein Fudazi | H. Moaiery